Tag: CRISPR cas 9

November 13, 2018

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
March 9, 2017

Genetics Facts for Investors

Punnett squares and phenotypes, chromatids and codominance: genetics, and all of its associated terms, isn’t the easiest field to understand....
January 4, 2017

Biotech Outlook 2017: After the Storm

Deep breaths, biotech investors. 2016 was a rough one—but the year ahead looks bright.
December 16, 2016

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, and ERS Genomics announced that the companies and their licensors have entered into a...
October 12, 2016

5 Future-Facing TSX Medical Device Stocks

Who says pharma and biotech are the pioneers of the life science sector?As these TSX medical device stocks show, innovation...